Eriko Katsuta

2.0k citations
82 papers · 1.6k indexed · h-index 24
Topics
Cancer Immunotherapy and Biomarkers (13 papers)Ferroptosis and cancer prognosis (12 papers)Cancer Cells and Metastasis (10 papers)

In The Last Decade

Eriko Katsuta

76 papers receiving 1.6k citations

Peers

Eriko Katsuta
Comparison fields: 5 of 76
  • Molecular Biology 773
  • Oncology 695
  • Cancer Research 501
  • Pulmonary and Respiratory Medicine 403
  • Immunology 372
Replace Chongbiao Huang with:
Chongbiao Huang China
Peter Horak Germany
Sang-Bae Kim United States
Nilgun Tasdemir United States
Maojie Yang United States
Charlotte Kopitz Germany
Neil E. Bhola United States
Haizhu Song China
Xiangpeng Dai United States
Teresa Klinowska United Kingdom
Eriko Katsuta relative to Chongbiao Huang China Chongbiao Huang's profile →
Citations per field
00.5×1.5×2.2×
Chongbiao Huang · 1×
Citations per year

Countries citing papers authored by Eriko Katsuta

Since Specialization
Citations

This map shows the geographic impact of Eriko Katsuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Katsuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Katsuta more than expected).

Fields of papers citing papers by Eriko Katsuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Katsuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Katsuta. The network helps show where Eriko Katsuta may publish in the future.

Co-authorship network of co-authors of Eriko Katsuta

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Katsuta. A scholar is included among the top collaborators of Eriko Katsuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Katsuta. Eriko Katsuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 6
4 9
5 0
6 14
7 2
8 9
9 9
10 49
11 38
12 97
13 35
14 21
15 165
16 24
17 13
18 48
19 35
20 1

About Eriko Katsuta

Eriko Katsuta is a scholar working on Cancer Research, Oncology and Immunology, having authored 82 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Ferroptosis and cancer prognosis (12 papers) and Cancer Cells and Metastasis (10 papers). The work is most often cited by research in Cancer Research (501 citations), Oncology (695 citations) and Immunology (372 citations). Eriko Katsuta has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Kazuaki Takabe, Li Yan, Masanori Oshi, Omar M. Rashid, Xuan Peng, Yoshihisa Tokumaru, Qianya Qi, Manabu Futamura, Nobuhisa Matsuhashi and Kazuhiro Yoshida. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026